About
Arushi Pandya is an associate in the Corporate Practice Group in the firm's Washington, D.C. office.
SCOTUS Punts on EMTALA Preemption Question
FDA Revisits and Updates Guidance on Addressing Misinformation – Ten Years Later
EMTALA: In the Spotlight
OIG Issues Favorable Advisory Opinion Regarding Patient Assistance Funds
CMS Issues CY2025 Medicare Advantage and Part D Final Rule
Time to Refresh? FDA Issues Draft Guidance on Key Information and Informed Consent
2024 Top-of-Mind Issues for Life Sciences Companies
2024 Top-of-Mind Issues for Life Sciences Companies
CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule
About
Arushi Pandya is an associate in the Corporate Practice Group in the firm's Washington, D.C. office.